{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:07:02Z","timestamp":1785751622638,"version":"3.56.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2041772"],"award-info":[{"award-number":["2041772"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R 01DA039100"],"award-info":[{"award-number":["R 01DA039100"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R 01AA030509"],"award-info":[{"award-number":["R 01AA030509"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuropharm.2026.110898","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:22:45Z","timestamp":1772209365000},"page":"110898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hypocretin receptor 1 blockade early in abstinence reduces future demand for cocaine"],"prefix":"10.1016","volume":"291","author":[{"given":"Shanna B.","family":"Samels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7828-1234","authenticated-orcid":false,"given":"Jessica K.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7695-8176","authenticated-orcid":false,"given":"I. Pamela","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-2215","authenticated-orcid":false,"given":"Emily M.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo A.","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110898_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1460-9568.2010.07114.x","article-title":"Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex","volume":"31","author":"Abdolahi","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2022.100029","article-title":"Incubation of cocaine craving coincides with changes in dopamine terminal neurotransmission","author":"Alonso","year":"2022","journal-title":"Addiction Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110898_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41386-020-00879-2","article-title":"Dopamine transporter function fluctuates across sleep\/wake state: potential impact for addiction","volume":"46","author":"Alonso","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopsych.2010.07.014","article-title":"Incubation of cue-induced cigarette craving during abstinence in human smokers","volume":"69","author":"Bedi","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110898_bib5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ejn.12866","article-title":"Orexin-1 receptor signaling increases motivation for cocaine-associated cues","volume":"41","author":"Bentzley","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00213-012-2899-2","article-title":"The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures","volume":"226","author":"Bentzley","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110898_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbb.2015.12.007","article-title":"The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats","volume":"142","author":"Bernosky-Smith","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.110898_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.euroneuro.2003.10.005","article-title":"Time-dependent changes in alcohol-seeking behaviour during abstinence","volume":"14","author":"Bienkowski","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110898_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2023.100104","article-title":"Hypocretin\/orexin receptor 1 knockdown in GABA or dopamine neurons in the ventral tegmental area differentially impact mesolimbic dopamine and motivation for cocaine","volume":"7","author":"Black","year":"2023","journal-title":"Addict. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib10","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","article-title":"Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers","volume":"29","author":"Borgland","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110898_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.07.027","article-title":"Hypocretin receptor 1 involvement in cocaine-associated behavior: therapeutic potential and novel mechanistic insights","volume":"1731","author":"Brodnik","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110898_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbr.2015.05.051","article-title":"Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep","volume":"291","author":"Brodnik","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110898_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuropharm.2017.07.032","article-title":"Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine","volume":"125","author":"Brodnik","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib15","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1523\/JNEUROSCI.0894-20.2020","article-title":"Chemogenetic manipulation of dopamine neurons dictates cocaine potency at distal dopamine transporters","volume":"40","author":"Brodnik","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4161\/chan.5.6.17120","article-title":"Mimicking synaptic effects of addictive drugs with selective dopamine neuron stimulation","volume":"5","author":"Brown","year":"2011","journal-title":"Channels"},{"key":"10.1016\/j.neuropharm.2026.110898_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1124\/jpet.114.212993","article-title":"Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter","volume":"349","author":"Calipari","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110898_bib18","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/npp.2013.136","article-title":"Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter","volume":"38","author":"Calipari","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13877","article-title":"Dopaminergic dynamics underlying sex-specific cocaine reward","volume":"8","author":"Calipari","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110898_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/npp.2014.238","article-title":"Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking","volume":"40","author":"Calipari","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib21","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.1074\/jbc.M117.787002","article-title":"Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding","volume":"292","author":"Challasivakanaka","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110898_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-025-02315-9","article-title":"Hypocretin receptor 1 blockade early in abstinence prevents incubation of cocaine seeking and normalizes dopamine transmission","author":"Clark","year":"2026","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib23","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/s41386-019-0458-9","article-title":"Experimental design and analysis for consideration of sex as a biological variable","volume":"44","author":"Diester","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-010-2048-8","article-title":"Hypocretin 1\/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration","volume":"214","author":"Espa\u00f1a","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110898_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","article-title":"Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area","volume":"111","author":"Fadel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110898_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchemneu.2016.10.004","article-title":"Phosphorylation mechanisms in dopamine transporter regulation","volume":"83\u201384","author":"Foster","year":"2017","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2026.110898_bib28","doi-asserted-by":"crossref","first-page":"29702","DOI":"10.1074\/jbc.M112.367706","article-title":"Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux","volume":"287","author":"Foster","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110898_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70817","article-title":"Reporting and misreporting of sex differences in the biological sciences","volume":"10","author":"Garcia-Sifuentes","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.110898_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/35084134","article-title":"Neuroadaptation. Incubation of cocaine craving after withdrawal","volume":"412","author":"Grimm","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110898_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1523\/JNEUROSCI.23-03-00742.2003","article-title":"Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving","volume":"23","author":"Grimm","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"115","author":"Hursh","year":"2008","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2026.110898_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbr.2004.07.012","article-title":"Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867","volume":"157","author":"Ishii","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110898_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0306-4522(92)90430-A","article-title":"Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum","volume":"50","author":"Klitenick","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2026.110898_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-017-4673-y","article-title":"Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling","author":"Levy","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110898_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/adb.12140","article-title":"Incubation of alcohol craving during abstinence in patients with alcohol dependence","volume":"20","author":"Li","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2026.110898_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00213-004-1860-4","article-title":"Cocaine seeking over extended withdrawal periods in rats: different time courses of responding induced by cocaine cues versus cocaine priming over the first 6 months","volume":"176","author":"Lu","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2026.110898_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuropharm.2004.06.027","article-title":"Incubation of cocaine craving after withdrawal: a review of preclinical data","volume":"47","author":"Lu","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-012-2681-5","article-title":"Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats","volume":"226","author":"Mahler","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110898_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110898_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00213-003-1491-1","article-title":"Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior","volume":"168","author":"Marinelli","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110898_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.npp.1301045","article-title":"AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues","volume":"32","author":"Mead","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib43","article-title":"Dopamine agonists for the treatment of cocaine dependence","volume":"2015","author":"Minozzi","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2026.110898_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146461","article-title":"Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil","volume":"1731","author":"Mohammadkhani","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110898_bib45","doi-asserted-by":"crossref","first-page":"E1648","DOI":"10.1073\/pnas.1315542111","article-title":"Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area","volume":"111","author":"Muschamp","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110898_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00213-010-2058-6","article-title":"A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid","volume":"214","author":"Oleson","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.110898_bib47","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/npp.2008.195","article-title":"Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake","volume":"34","author":"Oleson","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-61779-458-2_20","article-title":"Cocaine self-administration in rats: threshold procedures","volume":"829","author":"Oleson","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.110898_bib49","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41386-021-01173-5","article-title":"Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine","volume":"47","author":"Pantazis","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib50","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1016\/j.bmc.2015.07.013","article-title":"The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor","volume":"23","author":"Perrey","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110898_bib51","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1021\/jm400720h","article-title":"Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor","volume":"56","author":"Perrey","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110898_bib52","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/cn500246j","article-title":"Hypocretin\/orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1","volume":"6","author":"Prince","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib54","article-title":"Studying sex differences in rodent models of addictive behavior","volume":"1","author":"Radke","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.neuropharm.2026.110898_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pneurobio.2015.03.005","article-title":"The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors","volume":"130","author":"Root","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110898_bib56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.tins.2021.03.003","article-title":"Dopamine 'ups and downs' in addiction revisited","volume":"44","author":"Samaha","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-3-031-96364-3_7","article-title":"Monoamine transporters in drugs of abuse: insights from fast Scan cyclic voltammetry","volume":"46","author":"Samels","year":"2025","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110898_bib58","series-title":"The Orexin\/Hypocretin System","first-page":"99","article-title":"Hypocretin receptor 1 regulation of dopamine neurotransmission and motivated behavior","author":"Shaw","year":"2019"},{"key":"10.1016\/j.neuropharm.2026.110898_bib59","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/s41386-021-01009-2","article-title":"Individual differences in dopamine uptake in the dorsomedial striatum prior to cocaine exposure predict motivation for cocaine in male rats","volume":"46","author":"Shaw","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib60","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1523\/JNEUROSCI.4652-15.2016","article-title":"Cocaine self-administration produces long-lasting alterations in dopamine transporter responses to cocaine","volume":"36","author":"Siciliano","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1460-9568.2009.06844.x","article-title":"Orexin\/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking","volume":"30","author":"Smith","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib62","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S1471-1931(00)00023-9","article-title":"Anatomy of the dopamine system in the basal ganglia","volume":"23","author":"Smith","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib63","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/35079077","article-title":"Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons","volume":"411","author":"Ungless","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110898_bib64","article-title":"Effects of length of abstinence on decision-making and craving in methamphetamine abusers","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110898_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuropharm.2009.07.008","article-title":"Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure","volume":"58","author":"Winrow","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110898_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrn.2016.39","article-title":"Synaptic mechanisms underlying persistent cocaine craving","volume":"17","author":"Wolf","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110898_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2011.03.001","article-title":"Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures","author":"Yorgason","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2026.110898_bib68","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuropharm.2012.07.044","article-title":"Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats","volume":"63","author":"Zhou","year":"2012","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:45:53Z","timestamp":1776105953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":68,"alternative-id":["S0028390826000717"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110898","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypocretin receptor 1 blockade early in abstinence reduces future demand for cocaine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110898"}}